Skip to main content

Verismo Therapeutics

Philadelphia, United States

Verismo Therapeutics is a biotechnology company that develops CAR T cell therapy for the treatment of solid tumors.

$4.0M raised
Apr 2026
Corporate Round

Top Investors

HLB innovationBRV Capital ManagementHong Leong BankScaleReadyInstitute for Follicular Lymphoma Innovation

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Verismo Therapeutics

How much funding has Verismo Therapeutics raised?
Verismo Therapeutics has raised $4.0M in total funding. The most recent round was Corporate Round. The last funding was announced in April 2026.
Who are Verismo Therapeutics's investors?
Verismo Therapeutics's investors include HLB innovation, BRV Capital Management, Hong Leong Bank, ScaleReady, Institute for Follicular Lymphoma Innovation.
Where is Verismo Therapeutics headquartered?
Verismo Therapeutics is headquartered in Philadelphia, United States.
What does Verismo Therapeutics do?
Verismo Therapeutics is a biotechnology company that develops CAR T cell therapy for the treatment of solid tumors.
What stage is Verismo Therapeutics at?
Verismo Therapeutics is at the Corporate Round stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Verismo Therapeutics — Funding & Investors." VCBacked, April 15, 2026, https://www.vcbacked.co/company/verismo-therapeutics. Accessed June 17, 2026.
APA
VCBacked. (2026). Verismo Therapeutics — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/verismo-therapeutics
Wikipedia (cite web)
{{cite web |title=Verismo Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/verismo-therapeutics |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .